Important Safety Information
Prescribing Information
Indications and Usage
FAQ Icon
For U.S. Patients For U.S. Healthcare Professionals

Personalized Support

Living with acute intermittent porphyria (AIP) can be challenging, but there is help available. Check out the resources below.

Personalized education and support for women with AIP receiving treatment with PANHEMATIN

Patient Liason For Individuals Taking PANHEMATIN
Helga, Patient Liaison (PL)
Recordati Rare Diseases
Patient Support Services

The Patient Liaison (PL) program provides one-on-one support for patients and caregivers that may include*:

  • Providing education about acute intermittent porphyria (AIP) and how it can impact the body
  • Answering questions you might have about PANHEMATIN, such as questions about administration or how PANHEMATIN works
  • Helping you if issues arise accessing PANHEMATIN
  • Helping you to connect with resources regarding AIP
  • Helping you to create a personalized plan to prepare for AIP attacks
  • Providing PL program services in Spanish, if requested.

*Information provided by the PL program is for educational purposes only and is not intended to replace the care and advice of patients’ healthcare providers.

These services are provided at no additional cost to you by Recordati Rare Diseases (the maker of PANHEMATIN) to help you manage the PANHEMATIN therapy. For medical care, please contact your doctor or nearest urgent care provider.

To Get Started, Complete The Program Enrollment Opt-in Form:

COMPLETE THE OPT-IN FORM

The PL will contact you upon receipt of the opt-in form.

Watch these videos to learn more about the PANHEMATIN PL program:

Introducing the Patient Liaison program for patients receiving treatment with PANHEMATIN

Meet Helga, a Patient Liaison for patients receiving treatment with PANHEMATIN

How the Patient Liaison program for patients receiving treatment with PANHEMATIN has helped individuals living with AIP

Additional Reimbursement and Financial Support Programs

Recordati Rare Diseases has a free support program for eligible people living with AIP. The support program can also help caregivers, doctors and medical staff, and others who have questions about PANHEMATIN insurance coverage and related issues. Contact the Recordati Rare Diseases Patient Support Program hotline for:

Contact The Recordati Rare Diseases Patient Support Program

Monday-Friday from 9 AM to 5 PM ET
Hotline: 866-209-7604 (toll-free)
Fax: 866-209-7599

Access and Reimbursement Support

  • Insurance verification - Help with confirming that your insurance company will cover PANHEMATIN, and help with understanding your insurance benefits.
  • Insurance counseling - Help with exploring other insurance options if you are uninsured or underinsured for PANHEMATIN.
  • Additional approvals for coverage - Help work with your doctor's office and insurance company if additional approvals are needed.
  • Insurance company education - Help with educating insurers about PANHEMATIN to speed up decisions about coverage and payment.

Financial Assistance

  • Copay assistance program - Help with your copay if you're an eligible patient who receives PANHEMATIN infusions in an outpatient care setting.
  • Patient Assistance Program (PAP) - Assistance with accessing PANHEMATIN if you are an eligible patient who doesn't have insurance or are underinsured.
  • Additional referrals - Help with referrals to outside assistance sources when available.

Online Resources

For more information about AIP, check out these educational and support resources.

The APF educates people with porphyrias, their families, and doctors; raises funds for research; and promotes better patient care.

VISIT SITE

NORD is a group of health organizations dedicated to helping people with rare “orphan” diseases.

VISIT SITE

The Porphyrias Consortium, part of the Rare Diseases Clinical Research Network, helps patients, families, and doctors through joint efforts to improve the diagnosis, treatment, and prevention of illness and disability caused by the porphyrias.

VISIT SITE

The UPA is committed to improving the quality of life of people with porphyria and focuses on advancing disease awareness, research, and therapies.

VISIT SITE
LIVING WITH AIP Create a plan to help manage your AIP attacks About PANHEMATIN Learn how PANHEMATIN treats AIP

Indications And Usage

PANHEMATIN® is a hemin for injection prescription medication used to relieve repeated attacks of acute intermittent porphyria related to the menstrual cycle in affected women, after initial carbohydrate therapy is known or suspected to be inadequate.

Limitations of Use

  • Before giving PANHEMATIN, consider an appropriate trial of carbohydrates [i.e., 400 grams of glucose (a carbohydrate or sugar) per day for 1 to 2 days].
  • Attacks of porphyria may progress to a point where irreversible nerve damage has occurred. PANHEMATIN therapy is intended to prevent an attack from reaching the critical stage of nerve breakdown. PANHEMATIN is not effective in repairing nerve damage that has already occurred.

Indications and Important
Safety Information

+ See More

Indications And Usage

PANHEMATIN is a hemin for injection prescription medication used to relieve repeated attacks of acute intermittent porphyria related to the menstrual cycle in affected women, after initial carbohydrate therapy is known or suspected to be inadequate.

Important Safety Information

  • PANHEMATIN is not for patients known to be allergic to this drug.
  • Vein inflammation is possible. Use a large arm vein or a central line to administer PANHEMATIN to minimize the possibility of vein inflammation.
  • Elevated iron levels may occur. Your doctor must monitor your iron levels if you receive multiple courses of PANHEMATIN.
  • PANHEMATIN has a passing and mild blood thinning effect. Avoid blood thinners during PANHEMATIN therapy.
  • Reversible kidney shutdown has occurred when too high a dose of PANHEMATIN was given in a single dose.
  • PANHEMATIN may carry a risk of transmitting agents that can cause infections, such as viruses, and theoretically, the Creutzfeldt-Jakob disease (CJD) agent.
  • Most common side effects are headache, fever, infusion site reactions, and vein inflammation.
  • To report SUSPECTED SIDE EFFECTS, contact Recordati Rare Diseases Inc. at 1-888-575-8344, or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.
  • When taking PANHEMATIN, do not take drugs such as estrogens (e.g., oral contraceptives), barbiturates (drugs that help with sleep and used to treat epilepsy) or steroids (body hormone-like drugs), because such drugs can trigger an attack or make an attack worse.
For more information, please see PANHEMATIN Full Prescribing Information at www.recordatirarediseases.com.

Important Safety Information

You are about to leave the PANHEMATIN.com website and enter a website operated by an independent third party. The links to third-party websites contained on PANHEMATIN.com are provided solely for your convenience. Recordati Rare Diseases does not control the opinions, claims or comments contained on any third-party website linked to PANHEMATIN.com, and your activities at those websites will be governed by the policies and practices of those third parties.

OK to proceed to third-party website CANCEL to return to PANHEMATIN.com